Michael J Hayes - JoVE Visualize

Showing results (11-20 of 18) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 18 results.

The Journal of Organic Chemistry|July 6, 2002

Conjugated macrocycles related to the porphyrins. 21. Synthesis, spectroscopy, electrochemistry, and structural characterization of carbaporphyrinsTimothy D Lash, Michael J Hayes, John D Spence, et al.

The Journal of Nursing Administration|May 15, 2007

First-receiver hospital decontamination: an 8-step approach to a progressive and practical programDonna Edwards, Linda H Williams, John Beatty, et al.

Journal of Clinical Pharmacology|January 30, 2004

Absolute bioavailability of imatinib (Glivec) orally versus intravenous infusionBin Peng, Catherine Dutreix, Gunther Mehring, et al.

The Analyst|September 8, 2010

Capillary electrophoretic development of aptamers for a glycosylated VEGF peptide fragmentChristopher M Rose, Michael J Hayes, Gregory R Stettler, et al.

Bioorganic & Medicinal Chemistry Letters|June 26, 2003

Structure-based drug design of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complexMichael S South, Brenda L Case, Rhonda S Wood, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2008

Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of liver dysfunction: a study by the National Cancer Institute Organ Dysfunction Working GroupRamesh K Ramanathan, Merrill J Egorin, Chris H M Takimoto, et al.

Bioorganic & Medicinal Chemistry Letters|December 25, 2012

Discovery and SAR of PF-4693627, a potent, selective and orally bioavailable mPGES-1 inhibitor for the potential treatment of inflammationGraciela B Arhancet, Daniel P Walker, Sue Metz, et al.

Journal of Medicinal Chemistry|September 5, 2003

Design, parallel synthesis, and crystal structures of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complexJohn J Parlow, Brenda L Case, Thomas A Dice, et al.

Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 18 results.

The Journal of Organic Chemistry|July 6, 2002

Conjugated macrocycles related to the porphyrins. 21. Synthesis, spectroscopy, electrochemistry, and structural characterization of carbaporphyrinsTimothy D Lash, Michael J Hayes, John D Spence, et al.

The Journal of Nursing Administration|May 15, 2007

First-receiver hospital decontamination: an 8-step approach to a progressive and practical programDonna Edwards, Linda H Williams, John Beatty, et al.

Journal of Clinical Pharmacology|January 30, 2004

Absolute bioavailability of imatinib (Glivec) orally versus intravenous infusionBin Peng, Catherine Dutreix, Gunther Mehring, et al.

The Analyst|September 8, 2010

Capillary electrophoretic development of aptamers for a glycosylated VEGF peptide fragmentChristopher M Rose, Michael J Hayes, Gregory R Stettler, et al.

Bioorganic & Medicinal Chemistry Letters|June 26, 2003

Structure-based drug design of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complexMichael S South, Brenda L Case, Rhonda S Wood, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2008

Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of liver dysfunction: a study by the National Cancer Institute Organ Dysfunction Working GroupRamesh K Ramanathan, Merrill J Egorin, Chris H M Takimoto, et al.

Bioorganic & Medicinal Chemistry Letters|December 25, 2012

Discovery and SAR of PF-4693627, a potent, selective and orally bioavailable mPGES-1 inhibitor for the potential treatment of inflammationGraciela B Arhancet, Daniel P Walker, Sue Metz, et al.

Journal of Medicinal Chemistry|September 5, 2003

Design, parallel synthesis, and crystal structures of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complexJohn J Parlow, Brenda L Case, Thomas A Dice, et al.

Pageof 2